Search All News
New combination chemotherapies have improved survival for patients with pancreatic cancer, and oncologist Gulam Manji sees early signs that new treatments in trials may be even better.
Columbia researchers have identified a gene signature in localized prostate cancer that predicts the cancer’s odds of spreading and its response to a common treatment for advanced disease.
Immunotherapy, often ineffective against stomach cancer, was more effective when combined with chemotherapy and given earlier, finds a new study in mice.
Adam Bass, MD, will join the Herbert Irving Comprehensive Cancer Center as founding director of the Center for Precision Cancer Medicine and director of gastrointestinal oncology.
- October 22, 2020
Columbia's Eileen Connolly explains how radiation treatment for breast cancer has vastly improved in recent years due to advancements in technology and an increased understanding of the disease.
- September 25, 2020
Velocity, Columbia’s annual fundraiser for cancer research, has changed this year, with participants cycling, running, and even sailing to support cancer research and care.
- August 26, 2020
The Herbert Irving Comprehensive Cancer Center has been redesignated as a Comprehensive Cancer Center by the NCI, the federal government’s principal agency for cancer research, care, and training.
- August 20, 2020
A study of cancer patients with COVID-19 finds mortality is significantly higher than in the general population and Black patients are half as likely to receive the antiviral remdesivir.
- June 10, 2020
Compared to yearly screening, more frequent mammograms for women treated for early-stage breast cancer did not confer additional benefit, a study from Columbia University oncologists has found.
- April 20, 2020
Seizures are usually considered a side effect of brain cancer, but a new Columbia University study of mice suggests they may also fuel the further growth of brain tumors.